Pain Therapeutics Inc Sample Contracts

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT Pain Therapeutics, Inc.
Pain Therapeutics Inc • August 20th, 2018 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pain Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 20th, 2018 • Pain Therapeutics Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 15, 2018, between Pain Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

COMMON STOCK
Underwriting Agreement • June 20th, 2000 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Pain Therapeutics, Inc.
Pain Therapeutics Inc • August 20th, 2018 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pain Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of August 15, 2018.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 22nd, 2022 • Cassava Sciences Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 18, 2022, between Cassava Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Capital On DemandTM Sales Agreement
Cassava Sciences Inc • May 1st, 2023 • Pharmaceutical preparations • New York

Cassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:

Sales Agreement
Sales Agreement • March 27th, 2020 • Cassava Sciences Inc • Pharmaceutical preparations • New York

Cassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:

1 LEASE -----
Pain Therapeutics Inc • March 14th, 2000 • California
WITNESSETH
Research Agreement • March 14th, 2000 • Pain Therapeutics Inc • Indiana
RECITALS
Employment Agreement • March 14th, 2000 • Pain Therapeutics Inc • California
INDEMNIFICATION AGREEMENT
Indemnification Agreement • March 1st, 2022 • Cassava Sciences Inc • Pharmaceutical preparations • Delaware

This Indemnification Agreement (“Agreement”) is made as of this _____ day of _____________, 202_, by and between CASSAVA SCIENCES, INC., a Delaware corporation (the “Company”), and _________________________ (“Indemnitee”).

PAIN THERAPEUTICS, INC. and COMPUTERSHARE SHAREOWNER SERVICES LLC AMENDED AND RESTATED PREFERRED STOCK RIGHTS AGREEMENT Dated as of June 20, 2013
Preferred Stock Rights Agreement • June 20th, 2013 • Pain Therapeutics Inc • Pharmaceutical preparations • Delaware

This Amended and Restated Preferred Stock Rights Agreement (the “Agreement”) is dated as of June 20, 2013, between Pain Therapeutics, Inc., a Delaware corporation, (the “Company”), and Computershare Shareowner Services LLC (f/k/a Mellon Investor Services LLC) (the “Rights Agent”).

RECITALS
Rights Agreement • March 14th, 2000 • Pain Therapeutics Inc • California
LOGO]
Pain Therapeutics Inc • August 11th, 2000 • Pharmaceutical preparations
Form of Agreements for the 2008 Equity Incentive Plan PAIN THERAPEUTICS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT
Restricted Stock Unit Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California

Unless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Award Agreement (the “Award Agreement”).

PAIN THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT
Restricted Stock Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California

Unless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”).

PAIN THERAPEUTICS, INC. STOCK OPTION AWARD AGREEMENT
Stock Option Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California

Unless otherwise defined herein, the terms defined in the Pain Therapeutics, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Award Agreement (the “Award Agreement”).

STRICTLY CONFIDENTIAL Pain Therapeutics, Inc.
Letter Agreement • August 20th, 2018 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
LICENSE AGREEMENT
License Agreement • May 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York

This License Agreement (the “Agreement”) is made effective this day of , 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”

AutoNDA by SimpleDocs
FORM OF WARRANT AGREEMENT Dated as of January , 2024 between CASSAVA SCIENCES, INC. and COMPUTERSHARE INC. and COMPUTERSHARE TRUST COMPANY, N.A. as Warrant Agent Warrants for Shares of Common Stock of Cassava Sciences, Inc.
Warrant Agreement • January 3rd, 2024 • Cassava Sciences Inc • Pharmaceutical preparations • New York

WARRANT AGREEMENT, dated as of January , 2024 (this “Agreement”), between Cassava Sciences, Inc., a corporation incorporated under the laws of the state of Delaware (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively as Warrant Agent (the “Warrant Agent”) (each a “Party” and collectively, the “Parties”).

DEVELOPMENT AND LICENSE AGREEMENT
Development and License Agreement • April 24th, 2013 • Pain Therapeutics Inc • Pharmaceutical preparations • California
PAIN THERAPEUTICS, INC. PERFORMANCE SHARE AWARD AGREEMENT
Performance Share Award Agreement • July 30th, 2008 • Pain Therapeutics Inc • Pharmaceutical preparations • California

Unless otherwise defined herein, the terms defined in the 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Performance Share Award Agreement (the “Award Agreement”).

COLLABORATION AGREEMENT
Collaboration Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York

This COLLABORATION AGREEMENT is entered into as of November 9, 2005 (the “Effective Date”), by and between PAIN THERAPEUTICS, INC., a Delaware corporation having an address of 416 Browning Way, South San Francisco, California 94080 (“PTI”), and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”

AMENDMENT TO PREFERRED STOCK RIGHTS AGREEMENT BETWEEN PAIN THERAPEUTICS, INC. AND MELLON INVESTOR SERVICES LLC
Preferred Stock Rights Agreement • September 27th, 2006 • Pain Therapeutics Inc • Pharmaceutical preparations • Delaware

THIS AMENDMENT TO PREFERRED STOCK RIGHTS AGREEMENT (the “Amendment”) is made this 27th day of September 2006, by and between PAIN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and MELLON INVESTOR SERVICES LLC (the “Rights Agent”) to amend the Preferred Stock Rights Agreement, dated April 28, 2005, by and between the Company and the Rights Agent (the “Rights Agreement”).

Letter Agreement dated October 21, 2013 with Amendments to the License and Collaboration Agreements between the Registrant and King Pharmaceuticals, Inc.
Letter Agreement • February 5th, 2014 • Pain Therapeutics Inc • Pharmaceutical preparations

The signatories below are parties to agreements by which Pfizer is the sublicensee of rights granted by PTI as set forth in the License Agreement ("LA") dated as of November 9, 2005, as amended , by and between PTI and Pfizer, and the Collaboration Agreement ("CA"), dated as of November 9, 2005, as amended, by and between PTI and Pfizer. PTI is the licensee of rights granted by Durect Corporation ("Durect") as set forth in the Development and License Agreement dated as of December 19, 2002, as amended (the "DLA"), by and between PTI and Durect related to the development and commercialization of opioid agonist products incorporating the SABER Technology, the first of these being the oxycodone product Remoxy as defined in the CA.

SEPTEMBER 21, 2011 FIRST AMENDMENT TO LEASE AGREEMENT
Lease Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations

Re: Lease Agreement dated December 28, 2010, by and between STONECLIFF OFFICE, L.P., as Lessor, and PAIN THERAPEUTICS, INC., as Lessee, (herein after referred to as the “Lease Agreement”), demising 5,679 rentable square feet of space locally known as Suite 260 in the StoneCliff building, located at 7801 Capital of Texas Highway, Austin, Travis County, Texas, 78731.

Pain Therapeutics, Inc. 8,000,000 Shares1 Common Stock ($0.001 par value) Underwriting Agreement
Pain Therapeutics Inc • October 7th, 2004 • Pharmaceutical preparations • New York
CONSULTING AGREEMENT
Consulting Agreement • April 29th, 2004 • Pain Therapeutics Inc • Pharmaceutical preparations • California

This Consulting Agreement (“Agreement”) is made and entered into as of March 24, 2004 by and between Pain Therapeutics, Inc. (the “Company”), and Richard Stevens (“Consultant”). The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company and Consultant is able and willing to perform such services, on terms set forth more fully below. In consideration of the mutual promises contained herein, the parties agree as follows:

Pain Therapeutics, Inc. Shares[1] Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreement • September 4th, 2003 • Pain Therapeutics Inc • Pharmaceutical preparations • New York

Pain Therapeutics, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ ] shares of Common Stock, $0.001 par value (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ ] additional shares of Common Stock to cover over-allotments (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Any

December 21, 2005
Pain Therapeutics Inc • February 24th, 2006 • Pharmaceutical preparations
PAIN THERAPEUTICS, INC. EMPLOYMENT AGREEMENT
Employment Agreement • February 13th, 2009 • Pain Therapeutics Inc • Pharmaceutical preparations • California

This Employment Agreement (the “Agreement”) is made by and between Pain Therapeutics, Inc., a Delaware corporation (the “Company”) and Remi Barbier (“Executive”) as of July 1, 1998.

Time is Money Join Law Insider Premium to draft better contracts faster.